Quick Answer
Cabaletta Bio, Inc. reported Diluted EPS of $2.10 per share (loss) for fiscal year 2025.
Cabaletta Bio, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$2.10 | +10.3% |
| 2024 | -$2.34 | -41.8% |
| 2023 | -$1.65 | +8.8% |
| 2022 | -$1.81 | -0.6% |
| 2021 | -$1.80 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.44 | +29.0% | +39.7% |
| June 30, 2025 | -$0.73 | -30.4% | -2.8% |
| March 31, 2025 | -$0.71 | -39.2% | -14.5% |
| September 30, 2024 | -$0.62 | -67.6% | -10.7% |
| June 30, 2024 | -$0.56 | -51.4% | -9.8% |
| March 31, 2024 | -$0.51 | -13.3% | -37.8% |
| September 30, 2023 | -$0.37 | +5.1% | +0.0% |
| June 30, 2023 | -$0.37 | +17.8% | +17.8% |
- Cabaletta Bio, Inc. showed an increase of +10.3% in Diluted EPS compared to the prior fiscal year.
- Over the 2021–2025 period, Cabaletta Bio, Inc.’s diluted eps has declined by 16.7% (from $1.80 per share (loss) to $2.10 per share (loss)).
- The most recent figure is from Cabaletta Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: